Prescription drug use

Filter results by

Search Help
Currently selected filters that can be removed

Keyword(s)

Type

3 facets displayed. 0 facets selected.

Geography

2 facets displayed. 0 facets selected.

Content

1 facets displayed. 0 facets selected.
Sort Help
entries

Results

All (23)

All (23) (0 to 10 of 23 results)

  • Articles and reports: 75-006-X202400100001
    Description: Using data from the Canadian Community Health Survey, this study examines men’s and women’s coverage for four types of drug insurance plans (government-sponsored, employer-sponsored, association-sponsored and private drug insurance plans), disaggregated by various socioeconomic, demographic and geographical factors. The study further examines the extent of cost-related medication non-adherence among men and women, disaggregated by type of drug insurance plan.
    Release date: 2024-01-10

  • Articles and reports: 82-003-X202300300001
    Description: As Canada continues to experience an opioid crisis, it is important to understand the intersection between the demographic, socioeconomic and service use characteristics of those experiencing opioid overdoses to better inform prevention and treatment programs. This study aims to identify distinct groups of individuals with unique sets of characteristics and experiences among those who had an opioid overdose in British Columbia between 2014 and 2016.
    Release date: 2023-03-15

  • Articles and reports: 75-006-X202200100011
    Description:

    This study examines Canadians’ access to and use of pharmaceuticals using data from the 2021 Survey on Access to Health Care and Pharmaceuticals During the Pandemic, collected from March to May 2021. First, it examines the proportion and characteristics of Canadians who reported not having prescription insurance to cover medication costs, as well as those who reported that their prescription insurance was affected by the pandemic. Next, medication use, out-of-pocket spending on prescription medication, and non-adherence to prescription medication because of cost were examined. Analyses are presented across province, immigration status, and racialized groups, among other sociodemographic variables, and thus offers insight into potential inequities in access to pharmaceuticals in Canada.

    Release date: 2022-11-02

  • Stats in brief: 11-001-X202230635343
    Description: Release published in The Daily – Statistics Canada’s official release bulletin
    Release date: 2022-11-02

  • Stats in brief: 11-627-M2022071
    Description:

    Based on data from the 2021 Survey on Access to Health Care and Pharmaceuticals During the Pandemic, this infographic examines pharmaceutical access and use across regions and immigration status. It also looks out-of-pocket spending on medication and non-adherence to prescription medication because of cost.

    Release date: 2022-11-02

  • Stats in brief: 11-627-M2022054
    Description:

    An analysis of medical and non-medical cannabis consumption in the past 12 months among the population aged 15 or older, using the 2019/2020 Canadian Community Health Survey.

    Release date: 2022-10-17

  • Articles and reports: 82-003-X202200700001
    Description:

    There has been increasing scrutiny of opioid prescribing following injury given concerns that prescribed opioids may contribute to addiction and/or overdose. This study aimed to better understand the relationship between injury, opioids prescribed pre- and post-injury, and non-medical drug poisoning. Focusing on working age (15-65 years old) residents of the Fraser Health region, this study used a linked administrative dataset to better understand the relationships between injury, whether the injury was work-related or sustained outside of the workplace, pain management medication in the form of opioid and opioid agonist therapy prescriptions before and after injury, and potential non-medical drug poisoning.

    Release date: 2022-07-20

  • Articles and reports: 82-003-X202200600001
    Description:

    Estimates of polypharmacy (the concurrent use of five-or-more medications) have primarily been derived from prescription claims. Less is known about the use of non-prescription medications (alone or in combination with prescription medications) across the frailty spectrum or by sex. This study estimates the prevalence of polypharmacy (total, prescription, non-prescription, and concurrent prescription/non-prescription) overall, and by frailty, sex, and broad age groups.

    Release date: 2022-06-15

  • Articles and reports: 82-003-X202101200002
    Description:

    Reliance on the use of opioids to manage pain has increased over time, as have opioid-related morbidity and deaths. In 2019, Statistics Canada reported descriptive associations between demographic and geographic descriptors, certain mental health disorders, and problematic opioid pain relief medications (OPRM) use among Canada’s OPRM-using population aged 15 years or older. The goal of this analysis is to extend that previous research by using modelling to examine the associations for a broader range of characteristics. It strives to clarify which socioeconomic, health behaviour and psychosocial factors are independently and significantly associated with a greater likelihood of problematic OPRM use after accounting for other descriptors.

    Release date: 2022-01-19

  • Articles and reports: 82-003-X202100300001
    Description:

    Prescription medications are used throughout the life course, including among children and youth. This article describes prescription medication use in the past month among those aged 3 to 19 years.

    Release date: 2021-03-17
Data (1)

Data (1) ((1 result))

  • Table: 11-10-0139-01
    Geography: Canada, Province or territory
    Frequency: Annual
    Description:

    This table contains 264 series, with data for years 1997 - 2008 (not all combinations necessarily have data for all years). This table contains data described by the following dimensions (Not all combinations are available): Geography (11 items: Canada; Newfoundland and Labrador; Prince Edward Island; Nova Scotia; ...);  Spending category (6 items: Spending on prescription drugs greater than 0% of after tax income; Spending on prescription drugs greater than 1% of after tax income; Spending on prescription drugs greater than 2% of after tax income; Spending on prescription drugs greater than 3% of after tax income; ...);  Characteristics (4 items: Households; Low 95% confidence interval, households; High 95% confidence interval, households; Coefficient of variation for households).

    Release date: 2010-07-30
Analysis (22)

Analysis (22) (0 to 10 of 22 results)

  • Articles and reports: 75-006-X202400100001
    Description: Using data from the Canadian Community Health Survey, this study examines men’s and women’s coverage for four types of drug insurance plans (government-sponsored, employer-sponsored, association-sponsored and private drug insurance plans), disaggregated by various socioeconomic, demographic and geographical factors. The study further examines the extent of cost-related medication non-adherence among men and women, disaggregated by type of drug insurance plan.
    Release date: 2024-01-10

  • Articles and reports: 82-003-X202300300001
    Description: As Canada continues to experience an opioid crisis, it is important to understand the intersection between the demographic, socioeconomic and service use characteristics of those experiencing opioid overdoses to better inform prevention and treatment programs. This study aims to identify distinct groups of individuals with unique sets of characteristics and experiences among those who had an opioid overdose in British Columbia between 2014 and 2016.
    Release date: 2023-03-15

  • Articles and reports: 75-006-X202200100011
    Description:

    This study examines Canadians’ access to and use of pharmaceuticals using data from the 2021 Survey on Access to Health Care and Pharmaceuticals During the Pandemic, collected from March to May 2021. First, it examines the proportion and characteristics of Canadians who reported not having prescription insurance to cover medication costs, as well as those who reported that their prescription insurance was affected by the pandemic. Next, medication use, out-of-pocket spending on prescription medication, and non-adherence to prescription medication because of cost were examined. Analyses are presented across province, immigration status, and racialized groups, among other sociodemographic variables, and thus offers insight into potential inequities in access to pharmaceuticals in Canada.

    Release date: 2022-11-02

  • Stats in brief: 11-001-X202230635343
    Description: Release published in The Daily – Statistics Canada’s official release bulletin
    Release date: 2022-11-02

  • Stats in brief: 11-627-M2022071
    Description:

    Based on data from the 2021 Survey on Access to Health Care and Pharmaceuticals During the Pandemic, this infographic examines pharmaceutical access and use across regions and immigration status. It also looks out-of-pocket spending on medication and non-adherence to prescription medication because of cost.

    Release date: 2022-11-02

  • Stats in brief: 11-627-M2022054
    Description:

    An analysis of medical and non-medical cannabis consumption in the past 12 months among the population aged 15 or older, using the 2019/2020 Canadian Community Health Survey.

    Release date: 2022-10-17

  • Articles and reports: 82-003-X202200700001
    Description:

    There has been increasing scrutiny of opioid prescribing following injury given concerns that prescribed opioids may contribute to addiction and/or overdose. This study aimed to better understand the relationship between injury, opioids prescribed pre- and post-injury, and non-medical drug poisoning. Focusing on working age (15-65 years old) residents of the Fraser Health region, this study used a linked administrative dataset to better understand the relationships between injury, whether the injury was work-related or sustained outside of the workplace, pain management medication in the form of opioid and opioid agonist therapy prescriptions before and after injury, and potential non-medical drug poisoning.

    Release date: 2022-07-20

  • Articles and reports: 82-003-X202200600001
    Description:

    Estimates of polypharmacy (the concurrent use of five-or-more medications) have primarily been derived from prescription claims. Less is known about the use of non-prescription medications (alone or in combination with prescription medications) across the frailty spectrum or by sex. This study estimates the prevalence of polypharmacy (total, prescription, non-prescription, and concurrent prescription/non-prescription) overall, and by frailty, sex, and broad age groups.

    Release date: 2022-06-15

  • Articles and reports: 82-003-X202101200002
    Description:

    Reliance on the use of opioids to manage pain has increased over time, as have opioid-related morbidity and deaths. In 2019, Statistics Canada reported descriptive associations between demographic and geographic descriptors, certain mental health disorders, and problematic opioid pain relief medications (OPRM) use among Canada’s OPRM-using population aged 15 years or older. The goal of this analysis is to extend that previous research by using modelling to examine the associations for a broader range of characteristics. It strives to clarify which socioeconomic, health behaviour and psychosocial factors are independently and significantly associated with a greater likelihood of problematic OPRM use after accounting for other descriptors.

    Release date: 2022-01-19

  • Articles and reports: 82-003-X202100300001
    Description:

    Prescription medications are used throughout the life course, including among children and youth. This article describes prescription medication use in the past month among those aged 3 to 19 years.

    Release date: 2021-03-17
Reference (0)

Reference (0) (0 results)

No content available at this time.

Date modified: